Thexa Pharma Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 12.55 Cr
as on 15-12-2024
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 78.98 Cr
as on 15-12-2024
- Revenue -84.42%
(FY 2018)
- Profit -1557.22%
(FY 2018)
- Ebitda -1016.91%
(FY 2018)
- Net Worth -297.66%
(FY 2018)
- Total Assets -45.38%
(FY 2018)
About Thexa Pharma
The Corporate was formerly known as Nitya Fine Chem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 12.55 Cr.
The company has closed loans amounting to ₹78.98 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kiran Mamidala and Vijaya Ramisetti serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC056165
- Company No.
056165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2007
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Mahabub Nagar, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Thexa Pharma Private Limited offer?
Thexa Pharma Private Limited offers a wide range of products and services, including API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharma Ingredients & Raw Materials, Digestive System API, Esomeprazole Pellets, Omeprazole API.
Who are the key members and board of directors at Thexa Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Mamidala  | Director | 11-Dec-2019 | Current |
| Vijaya Ramisetti | Director | 11-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Thexa Pharma.
Thexa Pharma Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 84.42% decrease. The company also saw a substantial fall in profitability, with a 1557.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 297.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thexa Pharma?
In 2018, Thexa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 May 2015 | ₹39.00 Cr | Satisfied |
Others Creation Date: 25 May 2015 | ₹8.45 Cr | Satisfied |
Canara Bank Creation Date: 11 Dec 2013 | ₹15.53 Cr | Satisfied |
How Many Employees Work at Thexa Pharma?
Unlock and access historical data on people associated with Thexa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thexa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thexa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
